跳到正文
  1. WHO · Official News OData

    内分泌与代谢:One in four adolescents worldwide reported no active days in the previous week

    原文摘录:One in four adolescents worldwide reported not getting at least 60 minutes of physical activity on any day in the previous week. … Stand with science”, the theme of World Health Day 2026, marks a year-long campaign to highlight science as the foundation for protecting health and well-being worldwide

    关注理由:这条内分泌与代谢资料适合作为深入阅读入口,尤其要关注研究方法与结论是否匹配。

  2. WHO · Official News OData

    WHO建议ChAdOx1与mRNA-1469加入刚果(金)Tumaini试验,Bundibugyo病毒疫苗首次于疫情期间接受临床评估

    WHO候选疫苗优先技术咨询小组基于现有临床前和早期临床证据,建议将牛津大学与印度血清研究所的ChAdOx1及Moderna的mRNA-1469加入刚果(金)Tumaini试验,系针对Bundibugyo病毒的疫苗首次在疫情期间接受临床评估,待国家批准后入组。

    关注理由:针对Bundibugyo病毒的候选疫苗首次在疫情期间进入临床评估,Tumaini多疫苗试验与治疗研究并行推进,结果时间表明确,可跟踪疫情期间疫苗评价模式的验证进展。

  3. WHO · Official News OData

    感染病学:Progress against neglected tropical diseases requires sustained action

    原文摘录:WHO / Monika Mey Local health workers in Cambodia are trained in surveillance techniques, including stool examination using Kato-Katz, to detect schistosomiasis eggs, identify potential hotspots and support early detection and treatment. … int Related Global report on neglected tropical diseases 2026 Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021–2030 WHO's work on neglected tropical diseases More WHO Global Neglected Tropical Diseases Programme

    关注理由:关于感染病学的这条内容有明确出处,主要发现和适用人群可在原文中继续核查。

  4. WHO · Official News OData

    行业资料:Six climate and health actions could save 1.6 million lives and deliver trillions in benefits each year

    原文摘录:Six proven climate and health measures could save 1.6 million lives a year while delivering trillions of dollars in economic and fiscal gains, according to a new World Health Organization (WHO) report released today.

    关注理由:这条医学资料适合作为深入阅读入口,尤其要关注研究方法与结论是否匹配。

  1. EMA · Withdrawn Applications

    临床试验:Withdrawn application: Truqap, 16/09/2026

    原文摘录:Truqap - withdrawal of application for variation to marketing authorisation Application withdrawn The application for a change to this medicine's authorisation has been withdrawn capivasertib Post-authorisation Human Overview AstraZeneca AB withdrew its a … News on Truqap Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026 16/10/2026 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024 26/04/2024 More information on Truqap Truqap This page was last updated on 03/11/2026

    关注理由:这篇临床试验内容涉及随机对照研究,阅读重点可以放在研究分组、主要终点和随访结果上。

  2. WHO · Disease Outbreak News OData

    神经内科:Shamonda virus in human - France

    原文摘录:See all DONs related to this event Situation at a glance On 20 October 2026, the National IHR Focal Point (NFP) of France notified WHO regarding the first documented human infection with Shamonda virus (SHAV). … item/2026-DON623

    关注理由:这篇神经内科资料可用于了解领域进展,研究设计、结果和局限性值得一起阅读。

  1. EMA · News and Safety Reviews

    精神医学:Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026

    原文摘录:Image credit: © tadamichi | stock.adobe.com Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 2026 30 October 2026 PRAC starts review of depression and anxiety medicine Deanxit and a safety signal related to hu … eu All other enquiries please submit your request via the online form Follow us on Bluesky Related medicine information Flupentixol/melitracen-containing medicinal products - referral Topics Pharmacovigilance

    关注理由:如果关注精神医学,这篇内容值得阅读其研究对象、方法设计和主要发现。

  2. FDA · MedWatch Safety Alerts

    内分泌与代谢:Hospital Glucose Meter Correction: Nova Biomedical Updates Use Instructions for StatStrip Glucose Hospital Meter Systems

    原文摘录:This recall involves implementing additional recommendations on the use of the StatStrip Glucose Hospital Meter System while awaiting a software update. … 10/20/2026 The FDA issued a communication notifying the public of a Class I Recall

    关注理由:这篇内分泌与代谢内容涉及具体研究方向,原文中的样本、结局和限制有助于理解其价值。

  1. EMA · Withdrawn Applications

    肿瘤学:Withdrawn application: Ibrance, 15/10/2026

    原文摘录:Ibrance - withdrawal of application for variation to marketing authorisation Application withdrawn The application for a change to this medicine's authorisation has been withdrawn palbociclib Post-authorisation Human Overview Pfizer Europe MA EEIG withdre … News on Ibrance Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026 16/10/2026 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2016 (corrected) 21/09/2016 New treatment for breast cancer 16/09/2016 More information on Ibrance Ibrance This page was last updated on 28/10/2026

    关注理由:这篇肿瘤学内容涉及临床试验,适合了解研究正在回答什么问题,试验阶段和主要终点需以原文为准。

  1. WHO · Disease Outbreak News OData

    诊断与检测:Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo, Kenya and Nigeria

    原文摘录:See all DONs related to this event Read more about Ebola disease Situation at a glance Since the publication of the previous Disease Outbreak News on 8 October 2026, the Bundibugyo virus disease (BVD) outbreak has expanded geographically in the Democratic … item/2026-DON622

    关注理由:这条诊断与检测临床试验动态值得跟踪,后续可结合原文核对试验进度、研究设计与结果披露情况。

  2. EMA · News and Safety Reviews

    儿科学:AMA and EMA issue joint guidance on Ebola vaccine development

    原文摘录:Image credit: © peterschreiber.media | stock.adobe.com AMA and EMA issue joint guidance on Ebola vaccine development 23 October 2026 Clinical trial requirements defined for rapid development of Bundibugyo virus vaccines News Human Clinical trials Research … eu All other enquiries Please submit your request via the online form

    关注理由:这条儿科学资料涉及临床试验,入组条件、对照设置和研究阶段可以帮助判断结果适用于哪些人群。

  1. EMA · Withdrawn Applications

    儿科学:Withdrawn application: Kaftrio, 01/09/2026

    原文摘录:Kaftrio - withdrawal of application for variation to marketing authorisation Application withdrawn The application for a change to this medicine's authorisation has been withdrawn ivacaftor / tezacaftor / elexacaftor Post-authorisation Human Overview Vert … News on Kaftrio Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026 18/09/2026 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2025 28/02/2025 Combination of cystic fibrosis medicines to treat patients with rare mutations 28/02/2025 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15/09/2023 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12/11/2021 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 26/03/2021 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2020 26/06/2020 New medicine for cystic fibrosis patients 26/06/2020 More information on Kaftrio Kaftrio This page was last updated on 20/10/2026

    关注理由:如果关注儿科学,这条临床试验动态可用于了解研究设计,主要终点和试验阶段建议查看原文。

  1. EMA · News and Safety Reviews

    肿瘤学:EMA recommends authorisation of Rasonque for metastatic pancreatic cancer

    原文摘录:Image credit: © Chinnapong | stock.adobe.com EMA recommends authorisation of Rasonque for metastatic pancreatic cancer 15 October 2026 Phased review fast tracks assessment of medicine addressing unmet medical need News Human Innovation Medicines EMA’s hum … eu All other enquiries Please submit your request via the online form Follow us on Bluesky Related medicine information Rasonque

    关注理由:这条肿瘤学内容涉及相关临床或研究问题,建议查看原文中的方法与适用范围。

  1. WHO · Disease Outbreak News OData

    感染病学:Pneumonia of undetermined etiology - the Russian Federation

    原文摘录:Disease Outbreak News Pneumonia of undetermined etiology - Russian Federation 10 October 2026 See all DONs related to this event Situation at a glance On 2 October 2026, WHO became aware through media reports of the death of an employee of the Irkutsk Ant … item/2026-DON620 See all DONs related to this event

    关注理由:这条感染病学资料适合作为深入阅读入口,尤其要关注研究方法与结论是否匹配。

  1. EMA · Withdrawn Applications

    儿科学:Withdrawn application: Kalydeco, 01/09/2026

    原文摘录:Kalydeco - withdrawal of application for variation to marketing authorisation Application withdrawn The application for a change to this medicine's authorisation has been withdrawn ivacaftor Post-authorisation Human Overview Vertex Pharmaceuticals (Irelan … News on Kalydeco Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2026 18/09/2026 Combination of cystic fibrosis medicines to treat patients with rare mutations 28/02/2025 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 February 2024 23/02/2024 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15/09/2023 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021 12/11/2021 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 26/03/2021 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 September 2020 18/09/2020 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020 24/07/2020 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020 30/04/2020 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 October 2019 18/10/2019 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 October 2018 19/10/2018 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018 27/07/2018 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 September 2015 25/09/2015 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 June 2014 27/06/2014 More information on Kalydeco Kalydeco This page was last updated on 09/10/2026

    关注理由:这条儿科学临床试验动态值得跟踪,后续可结合原文核对试验进度、研究设计与结果披露情况。

  1. WHO · Disease Outbreak News OData

    诊断与检测:Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo

    原文摘录:See all DONs related to this event Read more about Ebola disease Situation at a glance On 5 October 2026, WHO was informed about a laboratory-confirmed imported case of Bundibugyo virus disease (BVD) in Kenya with travel history from the Democratic Republ … item/2026-DON619

    关注理由:这条诊断与检测临床试验动态值得跟踪,后续可结合原文核对试验进度、研究设计与结果披露情况。

  1. WHO · Disease Outbreak News OData

    诊断与检测:Ebola disease caused by Bundibugyo virus - Democratic Republic of the Congo

    原文摘录:See all DONs related to this event Read more about Ebola disease Situation at a glance Since the last Disease Outbreak News was published on 11 September 2026, the Bundibugyo virus outbreak in the Democratic Republic of the Congo has expanded further, wit … item/2026-DON621

    关注理由:关于诊断与检测的临床试验有新资料可供查看,主要终点、入组标准和研究阶段是几个重要阅读点。

已经到底了